1. Sato M, Kadomatsu T, Morinaga J, Kinoshita Y, Torigoe D, Horiguchi H, Ohtsuki S, Yamamura S, Kusaba R, Yamaguchi T, Yoshioka G, Araki K, Wakayama T, Miyata K, Node K, Oike Y, HINT1 suppression protects against age-related cardiac dysfunction by enhancing mitochondrial biogenesis. Mol Metab. 2025, 93, 102107. doi:10.1016/j.molmet.2025.102107
2. Hossain AS, Clarin M, Kimura K, Biggin G, Taga Y, Uto K, Yamagishi A, Motoyama E, Narenmandula, Mizuno K, Nakamura C, Asano K, Ohtsuki S, Nakamura T, Kanki S, Baldock C, Raja E, Yanagisawa H, Fibrillin-1 G234D mutation in the hybrid1 domain causes tight skin associated with dysregulated elastogenesis and increased collagen cross-linking in mice. Matrix Biol. 2025, 135, 24-38. doi:10.1016/j.matbio.2024.11.006
3. Ohtsuki S, Insulin receptor at the blood-brain barrier: Transport and signaling. Vitam Horm. 2024, 126, 113-24. doi:10.1016/bs.vh.2024.05.001
4. Ogata S, Ito S, Masuda T, Ohtsuki S, Isolation method of brain microvessels from small frozen human brain tissue for blood-brain barrier protein expression analysis. Fluids Barriers CNS. 2024, 21, 106. doi:10.1186/s12987-024-00609-6
5. Yamamoto T, Furukawa A, Zhou Y, Kono N, Kitajima S, Ohguchi H, Kawano Y, Ito S, Araki N, Ohtsuki S, Masuda T, Increased CSN5 expression enhances the sensitivity to lenalidomide in multiple myeloma cells. iScience. 2024, 27, 111399. doi:10.1016/j.isci.2024.111399
6. Ito S, Iwata Y, Otsuka M, Kaneko Y, Ogata S, Yagi R, Uemura T, Masuda T, Saito T, Saido T, Ohtsuki S, Progressive Amyloid-beta Accumulation in the Brain leads to Altered Protein Expressions in the Liver and Kidneys of APP knock-in Mice. J Pharm Sci. 2024, doi:10.1016/j.xphs.2024.10.051
7. Hamada Y, Masuda T, Ito S, Ohtsuki S, Regulatory Role of eIF2alphaK4 in Amino Acid Transporter Expression in Mouse Brain Capillary Endothelial Cells. Pharm Res. 2024, 41, 2213-23. doi:10.1007/s11095-024-03793-0
8. Toyoda T, Miura N, Kato S, Masuda T, Ohashi R, Matsushita A, Matsuda F, Ohtsuki S, Katakura A, Honda K, Identification of TPI1 As a potential therapeutic target in pancreatic cancer with dependency of TP53 mutation using multi-omics analysis. Cancer Sci. 2024, 115, 3622-35. doi:10.1111/cas.16302
9. Gu K, Kumabe H, Yamamoto T, Tashiro N, Masuda T, Ito S, Ohtsuki S, Improving Proteomic Identification Using Narrow Isolation Windows with Zeno SWATH Data-Independent Acquisition. J Proteome Res. 2024, 23, 3484-95. doi:10.1021/acs.jproteome.4c00149
10. 大槻純男:プロテオミクスにより得られる多面的なタンパク質情報、「あなたのラボから薬を生み出す アカデミア創薬の実践」、羊土社、55-61(2024)